Moneycontrol PRO
Loans
Loans
HomeNewsGlandpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight: How should you trade Berger Paints, Cholamandalam Financial, Havells, Amara Raja Energy, Prostarm Info, Jayaswal Neco, and others on September 12?

    Trade Spotlight: How should you trade Berger Paints, Cholamandalam Financial, Havells, Amara Raja Energy, Prostarm Info, Jayaswal Neco, and others on September 12?

    The market is expected to extend its bullish bias, given favourable technical and momentum indicators. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade ONGC, United Spirits, Action Construction Equipment, Gland Pharma, Blue Star, and others on January 2?

    Trade Spotlight: How should you trade ONGC, United Spirits, Action Construction Equipment, Gland Pharma, Blue Star, and others on January 2?

    Rangebound trading is expected to sustain in the upcoming sessions until the frontline indices give a strong close above all key moving averages. Below are some trading ideas for the near term.

  • Trade Spotlight | How to trade in Cummins India, BEML, Gland Pharma counters today

    Trade Spotlight | How to trade in Cummins India, BEML, Gland Pharma counters today

    Cummins India has been a big star performer in the past several months and maintained higher highs, higher lows formation. The stock has seen formation of bullish candlestick pattern on the daily charts, with above average volumes.

  • Trade Spotlight | What's your strategy for Aegis Logistics, JSW Energy, Gland Pharma today?

    Trade Spotlight | What's your strategy for Aegis Logistics, JSW Energy, Gland Pharma today?

    JSW Energy has seen a consolidation breakout and formed long bullish candlestick pattern on the daily scale with strong volumes. The stock traded well above all key moving averages (20, 50, 100 and 200-day EMA), which is a positive sign.

  • Trade Spotlight | Your game plan for Gland Pharma, Indian Bank, Manappuram Finance today

    Trade Spotlight | Your game plan for Gland Pharma, Indian Bank, Manappuram Finance today

    Gland Pharma has formed long bullish candlestick pattern with long lower shadow on the daily charts, indicating buying at lower levels, after a day of Dojj candlestick pattern formation.

  • Trade Spotlight | Your game plan for Alembic Pharma, Nippon Life, Gland Pharma today

    Trade Spotlight | Your game plan for Alembic Pharma, Nippon Life, Gland Pharma today

    Nippon Life has seen a breakout of horizontal resistance trendline adjoining highs of June 30 and July 12, and formed a bullish candlestick pattern on the daily timeframe with above average volumes. Further, it has also seen a golden crossover this month.

  • Trade Spotlight | What should you do with ABB India, Gland Pharma, Schneider Electric Infra on Friday?

    Trade Spotlight | What should you do with ABB India, Gland Pharma, Schneider Electric Infra on Friday?

    Gland Pharma jumped 5.6 percent to Rs 2,501 and formed small bodied bullish candle on the daily scale, while Schneider Electric Infrastructure climbed over 6 percent to Rs 145.3 and Inverted Hammer kind of pattern on the daily charts with above average volumes.

  • 12 stocks Motilal Oswal Financial recommends buying during ongoing market turmoil

    12 stocks Motilal Oswal Financial recommends buying during ongoing market turmoil

    With the possibility of escalation in tensions in Eastern Europe due to the Russia-Ukraine war keeping investors edgy, the brokerage firm says healthy earnings visibility can act as a cushion

  • 5 stocks that brokerages are betting on for 16-36% returns in 2022

    5 stocks that brokerages are betting on for 16-36% returns in 2022

    A cement-maker, a pharma firm and specialty chemicals company are among the top picks of broking firms for the new year

  • Hot Stocks | Gland Pharma, NIIT, L&T Technologies Services can give up to 13% return in short term, here is why

    Hot Stocks | Gland Pharma, NIIT, L&T Technologies Services can give up to 13% return in short term, here is why

    Vinay Rajani of HDFC Securities says markets are on their path to recovery, however, short-term bullish trend reversal will be confirmed only above 17,170

  • Holi special: Add colour to your portfolio with these 15 stocks

    Holi special: Add colour to your portfolio with these 15 stocks

    As the market seems to have the comfort of valuation now, it is time to lap up quality stocks, analysts point out.

  • AMFI's new list likely to include Gland Pharma, YES Bank, Adani Ent, 3 others in largecap list

    AMFI's new list likely to include Gland Pharma, YES Bank, Adani Ent, 3 others in largecap list

    The final/official list of large, mid and small-caps will be released by AMFI by the first week of January 2021, which will be effective for the February-to-July 2021 period.

  • Gland Pharma climbs 23% on listing day, should investors hold or book profits?

    Gland Pharma climbs 23% on listing day, should investors hold or book profits?

    Experts have a positive long-term view on the stock, given the company's strong financials and hold in the injectable business.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347